GC FUJI FIL LC
K051427 · GC America, Inc. · EMA · Aug 22, 2005 · Dental
Device Facts
| Record ID | K051427 |
| Device Name | GC FUJI FIL LC |
| Applicant | GC America, Inc. |
| Product Code | EMA · Dental |
| Decision Date | Aug 22, 2005 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3275 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
This product is a radiopaque light-cured reinforced glass ionomer restorative for use in the following recommended indications: 1. Class III and V restorations, particularly for cervical erosions and root surface caries. 2. Restoration of primary teeth 3. Core Build-up 4. Cases where radiopacity is required 5. As a base or a liner.
Device Story
GC Fuji Fil LC is a radiopaque, light-cured, reinforced glass ionomer restorative material. Used by dental professionals in clinical settings for restorative dentistry. Functions as a dental cement/filling material for Class III and V cavities, primary teeth, and core build-ups. Provides structural support and radiopacity for diagnostic imaging. Applied directly to the tooth preparation site by the clinician; light-cured to achieve hardening. Benefits patients by providing a durable, radiopaque restorative option for various dental defects.
Clinical Evidence
Bench testing only.
Technological Characteristics
Radiopaque light-cured reinforced glass ionomer restorative material. Classified as dental cement under 21 CFR 872.3275, Product Code EMA.
Indications for Use
Indicated for patients requiring dental restorations, including Class III and V restorations (cervical erosions, root surface caries), primary teeth restoration, core build-up, or use as a base/liner where radiopacity is required.
Regulatory Classification
Identification
Zinc oxide-eugenol is a device composed of zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp. Dental cement other than zinc oxide-eugenol is a device composed of various materials other than zinc oxide-eugenol intended to serve as a temporary tooth filling or as a base cement to affix a temporary tooth filling, to affix dental devices such as crowns or bridges, or to be applied to a tooth to protect the tooth pulp.
Related Devices
- K070319 — GC FUJI IX GP EXTRA · GC America, Inc. · Feb 26, 2007
- K172382 — GC Fuji Direct · GC America, Inc. · Apr 2, 2018
- K993973 — FUJI II LC CAPSULE · GC America, Inc. · Jan 11, 2000
- K991974 — FUTURA GLASS IONOMER SILVER REINFORCED · Ab Ardent · Sep 17, 1999
- K090817 — IONOLUX · Voco GmbH · Jul 23, 2009
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three stripes forming its body and wings. The logo is surrounded by a circular border containing the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA".
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 2 2 2005
Mr. Terry L. Joritz Director, Customer Care Group GC America, Incorporated 3737 West 127th Street Alsip, Illinois 60803
Re: K051427
Trade/Device Name: GC Fuji Fil LC Regulation Number: 21 CFR 872.3275 Regulation Name: Dental Cement Regulatory Class: II Product Code: EMA Dated: May 31, 2005 Received: June 6, 2005
Dear Mr. Joritz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device. subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Page 2 - Mr. Joritz
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Susan Runno
f Stacie Lin, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## Indications for Use
## 510(k) Number (if known): _K051427
## Device Name: GC Fuji Fil LC
## Indications for Use:
This product is a radiopaque light-cured reinforced glass ionomer restorative for use in the following recommended indications:
- 1. Class III and V restorations, particularly for cervical erosions and root surface caries.
- 2. Restoration of primary teeth
- 3. Core Build-up
- 4. Cases where radiopacity is required
- 5. As a base or a liner.
Prescription Use
(21 CFR Part 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR Part 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Suzer Russo
(Division S
Divi-y General Hospital,
Control Uercal Devices
i(k) Number kas7wa7
Page 1 of 1